Smith & Nephew SNATS Inc

Financials

Panoramica Estratto Conto Statistiche Dividendi

Flusso di cassa derivante dalle attività operative 935 M877 M468 M608 M987 M1.28 B — Flussi di cassa derivanti dalle attività di investimento 606 M691 M472 M448 M569 M406 M — Liquidità derivante dalle attività di finanziamento 1.16 B645 M926 M200 M86 M955 M — Liquidità libera 935 M877 M468 M608 M987 M1.28 B —

Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

SNN

Financials

Smith & Nephew SNATS Inc

Notizie

BofA conferma Buy su SharkNinja dopo dati di vendita solidi

BofA reiterates Buy on SharkNinja stock on strong sales data

SNN Launches ALLEVYN COMPLETE CARE Dressing for Wound Management

Il Chief Legal Officer di SharkNinja vende azioni per 2,77 milioni di dollari

Sharkninja chief legal officer sells $2.77 million in shares

BofA conferma Buy su SharkNinja per dati di vendita solidi

BofA reiterates Buy on SharkNinja stock on strong sales data

Smith & Nephew plc (SNN) Q4 2025 Earnings Call Transcript

Smith & Nephew plc 2025 Q4 - Results - Earnings Call Presentation (NYSE:SNN) 2026-03-02

Smith & Nephew Q4 2025: forte chiusura, margini al 19,7%

Smith & Nephew Q4 2025 slides: strong finish, margins expand to 19.7%

Smith & Nephew: utili Q4 2025 superano le previsioni sui ricavi